trametinib
Showing 26 - 50 of 133
Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,
Active, not recruiting
- Metastatic Malignant Neoplasm in the Brain
- +7 more
- Binimetinib
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)
Active, not recruiting
- Low-grade Glioma
- +2 more
- Trametinib
-
Calgary, Alberta, Canada
- +6 more
Oct 25, 2022
Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Boston
Active, not recruiting
- Metastatic Malignant Solid Neoplasm
- +2 more
- Biopsy
- +6 more
-
Boston, Massachusetts
- +1 more
Nov 8, 2022
Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)
Active, not recruiting
- Melanoma
- Dabrafenib
- +2 more
-
Sydney, New South Wales, Australia
- +2 more
Apr 4, 2022
Solid Tumors Trial in Worldwide (Trametinib, Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol))
Completed
- Solid Tumors
- Trametinib
- Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol)
-
Detroit, Michigan
- +6 more
Feb 7, 2022
BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,
Active, not recruiting
- BRAF V600E Mutation Present
- +9 more
- Dabrafenib
- +4 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)
Recruiting
- Anaplastic Thyroid Cancer
- +3 more
- Dabrafenib
- Trametinib
-
Basking Ridge, New Jersey
- +6 more
Jul 1, 2022
NSCLC Trial in China (Dabrafenib, Trametinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Dabrafenib
- Trametinib
-
Harbin, Heilongjiang, China
- +9 more
Jun 13, 2022
Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)
Active, not recruiting
- Melanoma
- MCS110
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 14, 2022
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade
Recruiting
- Low Grade Glioma (LGG) of Brain With BRAF Aberration
- +2 more
- Dabrafenib
- +2 more
-
Phoenix, Arizona
- +12 more
Apr 7, 2022
Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)
Recruiting
- Grade 1 Glioma
- +2 more
- Trametinib
- Vinblastine
-
Strasbourg, FranceCHU Strasbourg - France
Jul 7, 2022
Melanoma Trial in Boston (Trametinib, Dabrafenib, INCB039110)
Active, not recruiting
- Melanoma
- Trametinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 1, 2021
Rosacea, Erythematotelangiectatic Trial in Albany (Trametinib)
Recruiting
- Rosacea, Erythematotelangiectatic
- Trametinib
-
Albany, New YorkSamuel S. Stratton VA Medical Center
Nov 9, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Canada (Laboratory Biomarker Analysis, Pharmacological
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +3 more
-
Calgary, Alberta, Canada
- +4 more
Feb 10, 2022
Anaplastic Thyroid Cancer Trial in United States (Trametinib, Paclitaxel)
Active, not recruiting
- Anaplastic Thyroid Cancer
- Trametinib
- Paclitaxel
-
Basking Ridge, New Jersey
- +6 more
Mar 10, 2022
Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)
Recruiting
- Stage IV Melanoma
- Stage III Melanoma
- Trametinib
- Dabrafenib
-
Jette, Brussels, BelgiumUniversitair Ziekenhuis Brussel
Sep 29, 2021
Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,
Active, not recruiting
- Recurrent Rectal Cancer
- +6 more
- trametinib
- +2 more
-
Saint Louis, Missouri
- +3 more
Feb 15, 2022
Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)
Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- Everolimus
- Trametinib
-
Birmingham, Alabama
- +11 more
May 6, 2022
metAsTatI? melanOma Treated With dabrafeNib and trAmetinib in
Recruiting
- Melanoma Stage III
- +2 more
- Dabrafenib
- Trametinib
-
Barnaul, Alatai, Russian Federation
- +14 more
May 29, 2022
KRAS Gene Mutation, Metastatic Non-Squamous Non-Small Cell Lung Carcinoma, Recurrent Non-Squamous Non-Small Cell Lung Carcinoma
Active, not recruiting
- KRAS Gene Mutation
- +3 more
- Pembrolizumab
- Trametinib
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Nov 1, 2021